News on Object Management Group from BioPortfolio.com http://www.BioPortfolio.com Consolidated Object Management Group news from BioPortfolio.com Wed, 10 Feb 2010 14:19:39 GMT en Research and Markets: Mylan Laboratories - SWOT Framework Analysis Evaluates their Strengths, Weaknesses, Opportunities, and Thrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040676&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040676&THISHREF=http://c.moreover.com/click/here.pl%3fz2538830904%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040676&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040676&THISHREF=http://c.moreover.com/click/here.pl%3fz2538830904%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Research and Markets Adds Report: Eli Lilly and Company - SWOT Framework Analysishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039911&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039911&THISHREF=http://c.moreover.com/click/here.pl%3fz2538464264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039911&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039911&THISHREF=http://c.moreover.com/click/here.pl%3fz2538464264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Corticosteroid Treatment and Intensive Insulin Therapy for Septic Shock in Adultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041505&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041505&THISHREF=http://c.moreover.com/click/here.pl%3fz2539154272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041505&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041505&THISHREF=http://c.moreover.com/click/here.pl%3fz2539154272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of the American Medical Association: EMEA grants Genta's request for SME designationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042277&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042277&THISHREF=http://c.moreover.com/click/here.pl%3fz2539371652%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042277&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042277&THISHREF=http://c.moreover.com/click/here.pl%3fz2539371652%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041503&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041503&THISHREF=http://c.moreover.com/click/here.pl%3fz2539153378%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041503&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041503&THISHREF=http://c.moreover.com/click/here.pl%3fz2539153378%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of the American Medical Association: UH researchers create Walk n' Play iPhone application to keep track of physical activityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041203&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041203&THISHREF=http://c.moreover.com/click/here.pl%3fz2539033432%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041203&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041203&THISHREF=http://c.moreover.com/click/here.pl%3fz2539033432%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: ThromboGenics Positive Microplasmin Phase II Data Published In Ophthalmologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040860&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040860&THISHREF=http://c.moreover.com/click/here.pl%3fz2538907624%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040860&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040860&THISHREF=http://c.moreover.com/click/here.pl%3fz2538907624%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Angiology: Investigators at University of Minnesota, Department of Neurology have published new data on angiologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039728&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039728&THISHREF=http://c.moreover.com/click/here.pl%3fz2538342504%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039728&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039728&THISHREF=http://c.moreover.com/click/here.pl%3fz2538342504%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038827&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038827&THISHREF=http://c.moreover.com/click/here.pl%3fz2537788825%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038827&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038827&THISHREF=http://c.moreover.com/click/here.pl%3fz2537788825%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Nyer Medical Group, Inc., Announces Voluntary Delisting From NASDAQ and Closings of Sales of Assetshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042218&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042218&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361924%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042218&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042218&THISHREF=http://c.moreover.com/click/here.pl%3fz2539361924%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKSLA: Reform Pharma plc : Withdrawal From PLUS Marketshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036139&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036139&THISHREF=http://c.moreover.com/click/here.pl%3fz2536506552%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036139&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036139&THISHREF=http://c.moreover.com/click/here.pl%3fz2536506552%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInvestegate: Research and Markets: Pain Therapeutics - Drugs, Markets and Companieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035646&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035646&THISHREF=http://c.moreover.com/click/here.pl%3fz2536314784%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035646&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035646&THISHREF=http://c.moreover.com/click/here.pl%3fz2536314784%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: THE Aesthetic Academy Debuts in Beverly Hillshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037844&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037844&THISHREF=http://c.moreover.com/click/here.pl%3fz2537329595%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037844&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037844&THISHREF=http://c.moreover.com/click/here.pl%3fz2537329595%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Upgrades & Downgrades: Monsanto in the Moneyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035252&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035252&THISHREF=http://c.moreover.com/click/here.pl%3fz2536167243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035252&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035252&THISHREF=http://c.moreover.com/click/here.pl%3fz2536167243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMinyanville: Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038439&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038439&THISHREF=http://c.moreover.com/click/here.pl%3fz2537609520%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038439&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Object%20Management%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038439&THISHREF=http://c.moreover.com/click/here.pl%3fz2537609520%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAustralian NZ Journal of Public Health: